Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Homatropine methylbromide - Generic Drug Details

« Back to Dashboard

What are the generic sources for homatropine methylbromide and what is the scope of homatropine methylbromide patent protection?

Homatropine methylbromide
is the generic ingredient in eight branded drugs marketed by Mission Pharma, Wockhardt, King Pharms, Endo Pharms, Hi Tech Pharma, Actavis Mid Atlantic, Novel Labs Inc, Paddock Llc, Bio-pharm Inc, Halsey, Ivax Sub Teva Pharms, Abhai Llc, and Actavis Elizabeth, and is included in sixteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for homatropine methylbromide.

Summary for Generic Name: homatropine methylbromide

Tradenames:8
Patents:1
Applicants:13
NDAs:16
Drug Master File Entries: see list5
Bulk Api Vendors: see list48
Patent Applications: see list345
Drug Prices:see low prices
DailyMed Link:homatropine methylbromide at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Paddock Llc
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
homatropine methylbromide; hydrocodone bitartrate
SYRUP;ORAL205731-001Feb 15, 2017AARXNoNo► Subscribe► Subscribe
Mission Pharma
EQUIPIN
homatropine methylbromide
TABLET, CHEWABLE;ORAL086310-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Halsey
HYDROPANE
homatropine methylbromide; hydrocodone bitartrate
SYRUP;ORAL088066-001Jun 28, 1985DISCNNoNo► Subscribe► Subscribe
Endo Pharms
HYCODAN
homatropine methylbromide; hydrocodone bitartrate
TABLET;ORAL005213-001Jul 26, 1988DISCNYesNo► Subscribe► Subscribe
Mission Pharma
HOMAPIN-5
homatropine methylbromide
TABLET;ORAL086309-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot